We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Edwards Lifesciences Acquires JV in Japan

By HospiMedica staff writers
Posted on 21 Oct 2002
A cardiovascular business in Tokyo, Japan, has been acquired by Edwards Lifesciences Corp. (Irvine, CA, USA) for about US$22 million. The business, which had been operating as a joint venture of Edwards and Baxter International, Inc. (Deerfield, IL, USA; www.baxter.com), had net sales of around $170 million in 2001. The business began in 1968 as American Hospital Supply, Japan, and now has 18 regional sales offices throughout the country.

The business provides Edwards' products for heart valve therapy, critical care medicine, vascular therapies, and cardiovascular surgery to Japanese doctors. Edwards also serves in Japan as the exclusive third-party distributor of cardiology specialty products, such as pacemakers, intra-aortic balloon pumping systems, and angioplasty catheters.

"We are confident that the addition of our strong Japanese operations will contribute toward our aspiration of becoming the global leader in innovative solutions for people fighting advanced cardiovascular disease,” said Michael A. Mussallem, chairman and CEO of Edwards Lifesciences.




Related Links:
Edwards Lifesciences

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Oxygen Concentrator
Nuvo 8
New
Treadmill Test (TMT) System
GEMINI

Latest Business News

Philips and Mass General Brigham Collaborate on Improving Patient Care with Live AI-Powered Insights

Arab Health 2025 Celebrates Landmark 50th Edition

Boston Scientific Acquires Medical Device Company Intera Oncology